D-0703-2021 Class II Terminated
FDA drug recall D-0703-2021 was initiated by SUN PHARMACEUTICAL INDUSTRIES INC on Jul 29, 2021 and is designated Class II. Reason for recall: Presence of Forein Tablets/Capsules; Venlafaxine Tablets, USP 37.5 mg found in bottles labeled as Venlafaxine Tablets, USP, 50 mg The recall status is terminated (terminated Jun 8, 2023). Affected quantity: 2856 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Aug 18, 2021
- Initiation Date
- Jul 29, 2021
- Termination Date
- Jun 8, 2023
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 2856 bottles
Product description
Venlafaxine Tablets, USP 50 mg*, 100 Tablets Manufactured for Northstar Rx LLC Memphis, TN 38141 Manufactured by: ALKALOIDA Chemical Company Zrt. 4440 Tiszavasvari, Kabay Janos u.29.Hungary. Product of India NDC 16714-657-01
Reason for recall
Presence of Forein Tablets/Capsules; Venlafaxine Tablets, USP 37.5 mg found in bottles labeled as Venlafaxine Tablets, USP, 50 mg
Distribution pattern
Northstar Distribution Center 4853 Crumpler Rd. Memphis, TN 38141
Code information
AVK1175A, exp 9/2023
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0703-2021
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026